Healthcare Infection Control Practices Advisory Committee (HICPAC), 3155-3156 [2021-00603]
Download as PDF
<![CDATA[
3155
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
in the examination center primarily via
ACASI.
The biospecimens collected for
laboratory testing include urine and
blood. Serum, plasma, and urine
specimens are stored for future testing,
including genetic studies, if the
participant consents. Consent to store
DNA will continue in NHANES.
In 2021–22, we plan to add the
following laboratory tests: Serum
Terpenes: a-Pinene, b-Pinene, bMyrcene, D-3-Carene, Limonene, bCaryophyllene, a-Humulene;
Magnesium; HPV, serum; Alpha-1-acidglycoprotein (AGP); Vitamin D; Vitamin
A; Vitamin C; Acrylonitrile; Trans-fatty
Acids; Blood butyrylcholinesterase
activity, blood butyrylcholinesterase
concentration, and red blood cell
acetylcholinesterase activity;
Enterovirus D68; and COVID–19
serology.
In 2021–22, the following laboratory
tests will be modified: Hepatitis D (new
testing method, reportable findings); Sex
steroid hormone panel (now starting at
3+); Urine VOC metabolites (adding as
additional 7); trans, trans-Muconic acid;
N-Acetyl-S-phenyl-L-cysteine; N–2Furoylglycine; 2,5-Furandicarboxylic
acid; 5-Hydroxymethyl-2furancarboxylic acid; 5-Hydroxymethyl2-furoylglycine; and 5-Hydroxy-Nmethyl-2-pyrrolidone.
The laboratory tests cycling out for
2021–22 include: HPV swabs (male and
female); HPV oral rinse; Home water
sample collection to test for fluoride;
Salt home collection for iodine
assessment; Chromium/Cobalt;
Tuberculosis (TB); and Urine flow rate.
NHANES plans to conduct a dress
rehearsal prior to fielding the survey as
usual. This will be conducted in two
locations, among a sample of
approximately 300 volunteers per
location (approximately 600 total). The
program is taking this step to assure it
maintains the consistent quality
associated with data collection, given
the necessary pause in field operations
in 2020. The data collected during dress
rehearsal will be used for quality control
and training purposes. Dress rehearsal
data will not be part of the 2021–22
public release.
NHANES plans to conduct
developmental projects during NHANES
2021–22 with a focus on planning for
NHANES 2023 and beyond. These may
include activities such as tests of new
equipment, crossover studies between
current and proposed methods, test of
different study modes, settings, or
technology, outreach materials,
incentive strategies, sample storage and
processing, or sample designs.
Burden for individuals varies based
on their level of participation. For
example, infants and children tend to
have shorter interviews and exams than
adults because young people may have
fewer health conditions or medications
to report, certain exams are only
conducted on individuals 18 and older,
etc. In addition, adults often serve as
proxy respondents for young people in
their families.
Participation in NHANES is voluntary
and confidential. There is no cost to
respondents other than their time. CDC
requests a three-year approval, with
65,630 annualized hours of burden.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Individuals
Individuals
Individuals
Individuals
in
in
in
in
households
households
households
households
................................
................................
................................
................................
Individuals in households ................................
Individuals in households ................................
Individuals in households ................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–00691 Filed 1–13–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of meeting.
VerDate Sep<11>2014
20:43 Jan 13, 2021
Number of
respondents
Form name
Jkt 253001
Screener .........................................................
Household Interview .......................................
MEC Interview & Examination .......................
Day 1 and Day 2 Telephone Dietary Recall
& Dietary Supplements.
Flexible Consumer Behavior Survey Phone
Follow-Up.
Developmental Projects & Special Studies ...
24-hour wearable device projects ..................
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, limited only by audio phone
lines available. The public is also
welcome to listen to the meeting by
dialing 1–877–924–1748, passcode:
3380216. A total of 200 lines will be
available. Registration is required. To
register for this call, please go to
www.cdc.gov/hicpac.
SUMMARY:
The meeting will be held on
March 4, 2021, from 9 a.m. to 3 p.m.,
EST.
DATES:
The teleconference access is
1–877–924–1748, and the passcode is
3380216.
ADDRESSES:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden
per response
(in hours)
8,300
5,600
5,600
5,600
1
1
1
1
10/60
1
2.5
1.3
5,600
1
20/60
3,500
1,000
1
1
3
25
KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, 1600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027, Telephone (404)
498–0730; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\14JAN1.SGM
14JAN1
3156
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; the Long-term Care/Postacute Care Workgroup; the Neonatal
Intensive Care Unit Workgroup; and
updates from DHQP including DHQP’s
engagement on Coronavirus disease
response. Agenda items are subject to
change as priorities dictate.
Procedures for Public Comment: Time
will be available for public comment.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments.
Procedures for Written Comment: The
public may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is February 25, 2021. All
requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–00603 Filed 1–13–21; 8:45 am]
BILLING CODE 4163–18–P
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–1278]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Online Training
for Law Enforcement to Reduce Risks
Associated with Shift Work and Long
Work Hours to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on October 1,
2020 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function. Direct written comments and/
or suggestions regarding the items
contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Proposed Project
Online training for law enforcement
to reduce risks associated with shift
work and long work hours—
Reinstatement without Change—
National Institute for Occupational
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Police often work during the evening,
at night, and sometimes irregular and
long hours. Shift work and long work
hours are linked to many health and
safety risks due to disturbances to sleep
and circadian rhythms. These work
schedules also lead to difficulties with
personal relationships due to having
less time with family and friends, poor
mood from sleep deprivation, and
problems balancing work and personal
responsibilities. These work schedules
and inadequate sleep likely contribute
to health problems seen in police:
Shorter life spans, high occupational
injury rates, and burden of chronic
illnesses. One strategy to reduce these
risks is training programs to inform
employers and law enforcement officers
about the risks and strategies to reduce
their risks.
An Reinstatement is being requested
due to delays recruiting participants and
initiating data. The delays resulted from
the COVID–19 pandemic and the civil
unrest after George Floyd’s death on
May 25 2020. Law enforcement leaders
requested that the data collection be
delayed until the end of June 2020. As
a result, NIOSH is requesting a one-year
extension of the data collection end date
to May 31, 2021. This pilot study is part
of a project awarded National
Occupational Research Agenda (NORA)
funding. The National Institute for
Occupational Safety and Health is
authorized to carry out this data
collection through Occupational Safety
and Health Act of 1970.
The purpose of this project is to
develop a training program to relay the
risks linked to shift work and long work
hours and give workplace strategies for
employers and personal strategies for
the officers to reduce the risks. Once
finalized, the training will be available
on the NIOSH website. The training will
be pilot tested with 30 recent graduates
of a police academy and 30 experienced
officers. The study will recruit 60 law
enforcement officers during a 30-minute
phone call. All respondents will work
full-time on fixed night shifts. The pilot
test will use a pre-test–post-test design
to examine sleep (both duration and
quality), worktime sleepiness, and
knowledge retained. Pre-test measures
will be collected two weeks before the
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Pages 3155-3156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00603]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, limited only by audio phone lines available. The public is also
welcome to listen to the meeting by dialing 1-877-924-1748, passcode:
3380216. A total of 200 lines will be available. Registration is
required. To register for this call, please go to www.cdc.gov/hicpac.
DATES: The meeting will be held on March 4, 2021, from 9 a.m. to 3
p.m., EST.
ADDRESSES: The teleconference access is 1-877-924-1748, and the
passcode is 3380216.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027, Telephone (404)
498-0730; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic
[[Page 3156]]
updating of CDC guidelines and other policy statements regarding
prevention of healthcare-associated infections and healthcare-related
conditions.
Matters to be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; the Long-term
Care/Post-acute Care Workgroup; the Neonatal Intensive Care Unit
Workgroup; and updates from DHQP including DHQP's engagement on
Coronavirus disease response. Agenda items are subject to change as
priorities dictate.
Procedures for Public Comment: Time will be available for public
comment. Members of the public who wish to provide public comments
should plan to attend the public comment session at the start time
listed. Please note that the public comment period may end before the
time indicated, following the last call for comments.
Procedures for Written Comment: The public may submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed above. The deadline for
receipt of written public comment is February 25, 2021. All requests
must contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length. Written comments
received in advance of the meeting will be included in the official
record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-00603 Filed 1-13-21; 8:45 am]
BILLING CODE 4163-18-P
